United Biotech (P) Limited, India : Pharmaceutical Business

::	Research & Development
::	International Collaboration
::	Business Opportunities
::	Latest Events
::	Divisions At a Glance

:: Press Releases

:: In Licensing

:: Out Licensing

Somatostatin for Injection 250 mcg

Indications :

Acute severe gastrointestinal hemorrhage, resulting from gastric or duodenal ulcers, haemorrhagic gastritis and oesophageal varices

Treatment of intestinal, biliary and pancreatic fistulae

Symptomatic treatment of excessive secretion from endocrine tumors of the gastrointestinal tract

Treatment of postoperative complications and prophylaxis following pancreatic surgery

Co adjuvant treatment in diabetic ketoacidosis

Dosage :

Initial Dose : 250 mcg as bolus over 3 to 5 minutes.

Maintenance Dose : A continual infusion of 3.5 mcg/kg/hr. i.e. one 3mg vial given over 12 hr. The continual administration should last a minimum of 48 hr and a maximum of 120 hr. (5 days).

Coadjuvant treatment in diabetic ketoacidosis : In patients with ketoacidosis infusion of 100-500mcg/hr of somatostatin given concurrently with a bolus insulin injection.

Packing :

10 Vials of 250 mcg

Home

Careers

Site map